Mark Davies
Presidente en NEUROTECH INTERNATIONAL LIMITED .
Perfil
Mark Hamlin Davies is the founder of Cygnet Capital Pty Ltd.
(Investment Management), which was founded in 2003.
He held the title of General Manager at the firm.
Mr. Davies is also the founder of Cygnet Capital Pty Ltd.,1861 Capital Pty Ltd...
Mr. Davies's current job is Non-Executive Chairman at Neurotech International Ltd.
since 2019.
He is also the Chairman at Tryptamine Therapeutics Ltd.
Mr. Davies's former job was Non-Executive Chairman at Exopharm Ltd.
Mr. Davies obtained his undergraduate degree from The University of Western Australia.
Cargos activos de Mark Davies
| Empresas | Cargo | Inicio |
|---|---|---|
| NEUROTECH INTERNATIONAL LIMITED | Presidente | 16/08/2022 |
1861 Capital Pty Ltd.
 1861 Capital Pty Ltd. Financial ConglomeratesFinance 1861 Capital Pty Ltd. provides investment services. The private company is based in Dalkeith, Australia. The Australian company was founded by Mark Davies. Mark Davies has been the CEO since incorporation. | Fundador | - |
Antiguos cargos conocidos de Mark Davies.
| Empresas | Cargo | Fin |
|---|---|---|
Cygnet Capital Pty Ltd. (Investment Management)
 Cygnet Capital Pty Ltd. (Investment Management) Investment ManagersFinance Cygnet Capital Pty Ltd. (Investment Management) (Cygnet Capital-IM) is the investment management division of Cygnet Capital Pty Ltd., a brokerage firm headquartered in Melbourne, Australia. The firm was co-founded by Darien Jagger and Jonathan Rosham in 2003. Cygnet Capital-IM identifies and structures investment opportunities in emerging companies. | Fundador | - |
| EXOPHARM | Presidente | - |
Cygnet Capital Pty Ltd.
 Cygnet Capital Pty Ltd. Investment Banks/BrokersFinance Cygnet Capital Pty Ltd. is an investment firm that has been identifying and structuring investment opportunities in emerging companies for over twenty years. The private company is based in Melbourne, Australia. The Australian company engages founders with focus, talent, and hunger. and has subsidiaries in Australia. The company was founded in 2003 by Darien Jagger, Jonathan Rosham, Mark Davies. Jonathan Rosham has been the CEO since 2003. | Fundador | - |
Formación de Mark Davies.
| The University of Western Australia | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NEUROTECH INTERNATIONAL LIMITED | Health Technology |
| Empresas privadas | 4 |
|---|---|
Cygnet Capital Pty Ltd.
Cygnet Capital Pty Ltd. Investment Banks/BrokersFinance Cygnet Capital Pty Ltd. is an investment firm that has been identifying and structuring investment opportunities in emerging companies for over twenty years. The private company is based in Melbourne, Australia. The Australian company engages founders with focus, talent, and hunger. and has subsidiaries in Australia. The company was founded in 2003 by Darien Jagger, Jonathan Rosham, Mark Davies. Jonathan Rosham has been the CEO since 2003. | Finance |
Cygnet Capital Pty Ltd. (Investment Management)
Cygnet Capital Pty Ltd. (Investment Management) Investment ManagersFinance Cygnet Capital Pty Ltd. (Investment Management) (Cygnet Capital-IM) is the investment management division of Cygnet Capital Pty Ltd., a brokerage firm headquartered in Melbourne, Australia. The firm was co-founded by Darien Jagger and Jonathan Rosham in 2003. Cygnet Capital-IM identifies and structures investment opportunities in emerging companies. | Finance |
1861 Capital Pty Ltd.
1861 Capital Pty Ltd. Financial ConglomeratesFinance 1861 Capital Pty Ltd. provides investment services. The private company is based in Dalkeith, Australia. The Australian company was founded by Mark Davies. Mark Davies has been the CEO since incorporation. | Finance |
Exopharm Ltd.
 Exopharm Ltd. Pharmaceuticals: MajorHealth Technology Exopharm Ltd. engages in the research and development of biopharmaceutical drugs. The company was founded by Ian Dixon and Gregor Lichtfuss in 2013 and is headquartered in Camberwell, Australia. | Health Technology |
- Bolsa de valores
- Insiders
- Mark Davies
